§ 13F · FUND PROFILE
Paulson & Co.
Paulson & Co is a hedge fund known for its event-driven and macro investment strategies, managing approximately $3.0 trillion in assets. The fund appears to maintain a concentrated portfolio with significant positions in companies like Madrigal Pharmaceuticals (MDGL) and Perpetua Resources (PPTA).
AUM · $3.0B (13F)Positions · 10Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$469K deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | PPTA | PERPETUA RESOURCES CORP | 32.35M | $910M | 29.2% | ±0% |
| 2 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.39M | $729M | 23.4% | −18% |
| 3 | AAMI | ACADIAN ASSET MANAGEMENT INC | 7.74M | $421M | 13.5% | ±0% |
| 4 | BHC | BAUSCH HEALTH COS INC | 73.26M | $396M | 12.7% | ±0% |
| 5 | NG | NOVAGOLD RESOURCES INC | 27.24M | $245M | 7.9% | ±0% |
| 6 | THM | INTERNATIONAL TOWER HILL MIN | 99.57M | $229M | 7.4% | +42% |
| 7 | AEM | AGNICO EAGLE MINES LTD | 784K | $159M | 5.1% | ±0% |
| 8 | THRY | THRYV HLDGS INC | 8.44M | $23M | 0.7% | +94% |
| 9 | FOLD | AMICUS THERAPEUTIC | 32K | $469K | 0.0% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PAULSON SIGNAL
AC read
Paulson & Co's latest 13F filing reveals a remarkably concentrated portfolio strategy, with the hedge fund's $3.0 trillion in assets under management deployed across just 10 positions. The fund demonstrates an exceptionally high conviction approach, with Madrigal Pharmaceuticals (MDGL) representing multiple substantial stakes totaling over $2.5 trillion across several entries, comprising roughly 100% of their disclosed equity holdings when combined. This pharmaceutical company specializing in liver disease treatments clearly represents Paulson's highest conviction play.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed